Abstract
Among the most important insights into coronary and inflammatory disease is that the formation of vessel occluding placques is its essence an inflammatory process, that is counteracted by anti-inflammatory drugs Current therapeutical options of dealing with the increased challenge to public health posed by increased vessel disease are limited and unsatisfactory. Disturbingly, an increasing cohort of patients does not react to the immunosuppressive drugs available. Importantly, however, space travel is associated with well-tolerated immunosuppression and thus identification of the molecular mechanisms underlying this space travel-associated immunosuppression may have significant benefit for directing clinical research on earth. Devising an experimental set up for investigating the molecular details of space flightinduced immunosuppression is, however, fraught with difficulties. Two recent ESA-sponsored space missions (the Delta Taxi flight to ISS and Maser 10 sounding rocket mission) have now shown that these technical hurdles can be successfully tackled.
Keywords: centrifuges, cellular kinases, LPS, immune cells, immunosuppression
Current Genomics
Title: Using Microgravity for Defining Novel Anti-Atherosclerotic Therapy
Volume: 6 Issue: 6
Author(s): A. Verhaar, K. K. Krishnadath and M. P. Peppelenbosch
Affiliation:
Keywords: centrifuges, cellular kinases, LPS, immune cells, immunosuppression
Abstract: Among the most important insights into coronary and inflammatory disease is that the formation of vessel occluding placques is its essence an inflammatory process, that is counteracted by anti-inflammatory drugs Current therapeutical options of dealing with the increased challenge to public health posed by increased vessel disease are limited and unsatisfactory. Disturbingly, an increasing cohort of patients does not react to the immunosuppressive drugs available. Importantly, however, space travel is associated with well-tolerated immunosuppression and thus identification of the molecular mechanisms underlying this space travel-associated immunosuppression may have significant benefit for directing clinical research on earth. Devising an experimental set up for investigating the molecular details of space flightinduced immunosuppression is, however, fraught with difficulties. Two recent ESA-sponsored space missions (the Delta Taxi flight to ISS and Maser 10 sounding rocket mission) have now shown that these technical hurdles can be successfully tackled.
Export Options
About this article
Cite this article as:
Verhaar A., Krishnadath K. K. and Peppelenbosch P. M., Using Microgravity for Defining Novel Anti-Atherosclerotic Therapy, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774482972
DOI https://dx.doi.org/10.2174/138920205774482972 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Analytical Methods for Metallothionein Detection
Current Analytical Chemistry Regulation and Function of DNA and Histone Methylations
Current Pharmaceutical Design The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Biochemical Properties of Indoleamine 2,3-dioxygenase: From Structure to Optimized Design of Inhibitors
Current Medicinal Chemistry Cardiovascular Biology of Interleukin-6
Current Pharmaceutical Design Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics
Current Gene Therapy Molecular Advances Toward the Understanding of the Patho-Biology of Idiopathic Myelofibrosis
Current Immunology Reviews (Discontinued) Disodium Phosphate of Novel Pyrazole-Linked Norcantharidin Analogs:Design, Synthesis and their Anticancer Evaluation
Letters in Drug Design & Discovery Driving Neural Stem Cells Towards a Desired Phenotype
Current Stem Cell Research & Therapy Current Developments in the Therapeutic Potential of S-Nitrosoglutathione, an Endogenous NO-Donor Molecule
Current Pharmaceutical Biotechnology In Situ Gene Therapy for Prostate Cancer
Current Gene Therapy Recent Developments of DNA Poisons - Human DNA Topoisomerase IIα Inhibitors - as Anticancer Agents
Current Pharmaceutical Design MicroRNA Dysregulation in the Myelodysplastic Syndromes
MicroRNA Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Current Pharmaceutical Biotechnology Importance of P-gp PET Imaging in Pharmacology
Current Pharmaceutical Design Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective
Current Medicinal Chemistry Traditional Chinese Medicines (TCMs) for Molecular Targeted Therapies of Tumours
Current Drug Discovery Technologies Editorial (Hot Topic:Recent Advance in the Studies of Beta-glucans for Cancer Therapy)
Anti-Cancer Agents in Medicinal Chemistry ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update
Current Topics in Medicinal Chemistry Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets